Krka d. d (KRK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Krka d. d (KRK) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł128.16 Million ≈ $35.27 Million USD) by net assets (zł2.31 Billion ≈ $634.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Krka d. d - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Krka d. d's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Krka d. d total liabilities for a breakdown of total debt and financial obligations.
Krka d. d Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Krka d. d ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Jingsheng Mech Electric
SHE:300316
|
-0.003x |
|
Campbell’s Co
NYSE:CPB
|
0.069x |
|
BrightSpring Health Services, Inc. Common Stock
NASDAQ:BTSG
|
0.123x |
|
Sartorius Aktiengesellschaft
XETRA:SRT3
|
0.020x |
|
Oracle Financial Services Software Limited
NSE:OFSS
|
0.140x |
|
Baiyin Nonferrous Group Co Ltd
SHG:601212
|
0.043x |
|
Zions Bancorporation
NASDAQ:ZION
|
0.064x |
|
AZUL SA PFD ADR 1
F:8AZA
|
N/A |
Annual Cash Flow Conversion Efficiency for Krka d. d (2010–2024)
The table below shows the annual cash flow conversion efficiency of Krka d. d from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see KRK company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł2.24 Billion ≈ $615.87 Million |
zł360.93 Million ≈ $99.33 Million |
0.161x | +54.85% |
| 2023-12-31 | zł2.18 Billion ≈ $600.45 Million |
zł227.25 Million ≈ $62.54 Million |
0.104x | -52.37% |
| 2022-12-31 | zł2.14 Billion ≈ $588.55 Million |
zł467.65 Million ≈ $128.70 Million |
0.219x | +8.69% |
| 2021-12-31 | zł1.92 Billion ≈ $528.16 Million |
zł386.10 Million ≈ $106.26 Million |
0.201x | -2.30% |
| 2020-12-31 | zł1.75 Billion ≈ $482.12 Million |
zł360.76 Million ≈ $99.29 Million |
0.206x | -1.75% |
| 2019-12-31 | zł1.67 Billion ≈ $458.92 Million |
zł349.52 Million ≈ $96.19 Million |
0.210x | +11.35% |
| 2018-12-31 | zł1.54 Billion ≈ $423.90 Million |
zł289.95 Million ≈ $79.80 Million |
0.188x | +22.92% |
| 2017-12-31 | zł1.49 Billion ≈ $409.44 Million |
zł227.83 Million ≈ $62.70 Million |
0.153x | +3.61% |
| 2016-12-31 | zł1.44 Billion ≈ $397.53 Million |
zł213.49 Million ≈ $58.76 Million |
0.148x | -25.23% |
| 2015-12-31 | zł1.41 Billion ≈ $386.95 Million |
zł277.94 Million ≈ $76.49 Million |
0.198x | +56.41% |
| 2014-12-31 | zł1.35 Billion ≈ $372.06 Million |
zł170.87 Million ≈ $47.03 Million |
0.126x | -44.37% |
| 2013-12-31 | zł1.33 Billion ≈ $366.75 Million |
zł302.75 Million ≈ $83.32 Million |
0.227x | +1.26% |
| 2012-12-31 | zł1.24 Billion ≈ $341.41 Million |
zł278.33 Million ≈ $76.60 Million |
0.224x | +3.51% |
| 2011-12-31 | zł1.14 Billion ≈ $313.68 Million |
zł247.06 Million ≈ $67.99 Million |
0.217x | +25.79% |
| 2010-12-31 | zł1.05 Billion ≈ $289.89 Million |
zł181.52 Million ≈ $49.96 Million |
0.172x | -- |
About Krka d. d
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company's prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolis… Read more